To determine whether the level of STAG2 protein expression impacts patient outcomes in bladder cancer, we utilized a TMA comprised of 346 muscle-invasive and non–muscle-invasive bladder tumors. The gene discussed is STAG2; the disease is urinary bladder carcinoma.